The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proton Technologies

26 Sep 2023 07:00

RNS Number : 5869N
Sabien Technology Group PLC
26 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

26 September 2023

 

Sabien Technology Group plc

("Sabien", the "Company" or the "Group")

 

Proton Technologies

 

Sabien Technology Group plc (AIM:SNT), the company focused on a green aggregation strategy, today announces that it has reviewed the value of its investment in Proton Technologies Canada Inc., ("Proton") following the proposed investment in and restructuring of Proton. 

 

On 14 October 2021, Sabien invested £100,000 in Proton, giving the Company a 0.08% shareholding. Subsequently, Sabien entered into a licensing agreement with Proton on 1 February 2022. This agreement allowed Sabien to deploy Proton's technology within the UK and the right to install a plant for the City Oil Field, Inc. plastic to oil technology on Proton's Saskatchewan site. Sabien retains the rights conferred by this licensing agreement.

 

On 8 September 2023, Proton informed its shareholders that it had received a proposal from a third party to inject new capital, restructure its balance sheet, and reform its management team (the "Proposal"). The Proposal remains subject to shareholder approval.

 

Following a review of the Proposal and ahead of approval by Proton shareholders, the Board of Sabien has concluded that the value of the Company's stake (£100,000) may require a material impairment provision in the accounts for the financial year to 30 June 2023. The Board expects that this provision will allow for a potential material diminution in the value of existing Proton equity to reflect the notional value of Proton ascribed by the Proposal. The level of provision will require agreement with the Company's auditors as part of the current audit process. Details of the provision, if any, will be provided in the Company's final results which are expected to be published in October 2023.

 

Richard Parris, Executive Chairman of Sabien, commented:

 

"While it is disappointing to provide for a possible short-term reduction in Proton's equity value, the Board is encouraged by the constructive details of the Proposal. It is clear that Proton requires a larger capital base from which to develop its leading hydrogen technology and we are supportive of the intention to re-balance the business. It remains to be seen as to the outcome of this Proposal, but Sabien is intent on a prudent approach to its balance sheet and the values contained within it."

 

For Further Information:

 

Sabien Technology Group plc

Richard Parris, Executive Chairman

Scott Fulton, Investor Relations 

 

 

 

+44 20 7993 3700

Scott.fulton@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDCCSDDGXU
Date   Source Headline
18th Nov 20153:33 pmRNSResult of AGM
18th Nov 201511:08 amRNSAGM Statement
26th Oct 201512:39 pmRNSDespatch of Annual Report and Notice of AGM
23rd Oct 20158:36 amRNSDirectorate Change
8th Oct 20159:39 amRNSDirector/PDMR Shareholding
7th Oct 20157:00 amRNSFinal Results
30th Sep 20156:16 pmRNSAppointment of Director
4th Aug 20155:05 pmRNSHolding(s) in Company
4th Aug 20153:03 pmRNSHolding(s) in Company
3rd Aug 20152:33 pmRNSHolding(s) in Company
3rd Aug 201511:40 amRNSHolding(s) in Company
28th Jul 20152:39 pmRNSDirector/PDMR Shareholding
28th Jul 20157:00 amRNSAdmission of Placing and Subscription Shares
20th Jul 20157:00 amRNSIssue of Equity
15th Jun 20157:00 amRNSTrading Statement
7th Apr 20156:03 pmRNSDirector/PDMR Shareholding
27th Mar 20156:04 pmRNSDirector/PDMR Shareholding
16th Mar 20155:28 pmRNSDirector Shareholding
10th Feb 20157:00 amRNSHalf Yearly Report
7th Jan 20159:38 amRNSHolding(s) in Company
7th Jan 20159:36 amRNSHolding(s) in Company
20th Nov 20149:27 amRNSAGM Statement
27th Oct 20144:43 pmRNSDispatch of Annual Report and notice of AGM
9th Oct 20149:35 amRNSDividend Declaration
7th Oct 20147:00 amRNSPreliminary results for the year to 30 June 2014
3rd Oct 20143:54 pmRNSHolding(s) in Company
30th Sep 20149:39 amRNSHolding(s) in Company
12th Aug 20144:11 pmRNSHolding(s) in Company
6th Aug 20144:30 pmRNSHolding(s) in Company
1st Aug 201411:03 amRNSExercise of Warrants
8th Jul 20147:00 amRNSPost close trading update
29th May 20147:00 amRNSTrading Statement
28th Mar 20142:58 pmRNSDirector/PDMR Shareholding
3rd Mar 20147:00 amRNSOrders received
14th Feb 20145:01 pmRNSHolding(s) in Company
11th Feb 20147:00 amRNSInterim results
16th Jan 201410:58 amRNSDirector Shareholding
20th Nov 20134:32 pmRNSResult of AGM
28th Oct 20134:55 pmRNSNotice of AGM
23rd Oct 201312:19 pmRNSPropose Dividend Declaration
22nd Oct 20134:48 pmRNSHolding(s) in Company
10th Oct 201310:18 amRNSHoldings in Company
7th Oct 20137:00 amRNSPublic Sector Tender Award
1st Oct 20137:00 amRNSPreliminary Final Results
9th Jul 201312:45 pmRNSFurther Orders Received
8th Jul 20137:00 amRNSTrading Statement
7th Jun 20137:00 amRNSFurther orders received
28th May 20137:00 amRNSNew orders received
10th Apr 20137:00 amRNSContract with Norland
3rd Apr 201311:04 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.